4,959
Views
7
CrossRef citations to date
0
Altmetric
Review Article

Dietary advanced glycation end-products elicit toxicological effects by disrupting gut microbiome and immune homeostasis

&
Pages 93-104 | Received 12 May 2021, Accepted 20 Jul 2021, Published online: 26 Aug 2021

Figures & data

Figure 1. Structures of common AGEs. Modified from Akıllıoğlu and Gökmen (2019).

Figure 1. Structures of common AGEs. Modified from Akıllıoğlu and Gökmen (2019).

Figure 2. Dietary advanced glycation end-products (AGEs) induce toxicological effects by activating RAGE, modulating gut microbiota and inducing collagen crosslinking – potential roles in severity of COVID-19, aging, obesity and Type 2 diabetes. ADME: Absorption, distribution, metabolism, and excretion.

Figure 2. Dietary advanced glycation end-products (AGEs) induce toxicological effects by activating RAGE, modulating gut microbiota and inducing collagen crosslinking – potential roles in severity of COVID-19, aging, obesity and Type 2 diabetes. ADME: Absorption, distribution, metabolism, and excretion.

Figure 3. Schematic representation of paradoxical control of pro- and anti-inflammation by RAGE activation.

Figure 3. Schematic representation of paradoxical control of pro- and anti-inflammation by RAGE activation.

Figure 4. Differential immunomodulating capabilities of EGPs and AGEs. (A) Structure of glucose-derived Amadori compounds (early glycation products). R = protein/peptide/amino acid. (B) Comparison of EGPs and AGEs in modulating cytokine/chemokine production. Modified from Chen and Guo (Citation2019). No: no significant change when compared to non-reacted control. aValue significantly different from EGPs but not from non-reacted control.

Figure 4. Differential immunomodulating capabilities of EGPs and AGEs. (A) Structure of glucose-derived Amadori compounds (early glycation products). R = protein/peptide/amino acid. (B) Comparison of EGPs and AGEs in modulating cytokine/chemokine production. Modified from Chen and Guo (Citation2019). No: no significant change when compared to non-reacted control. aValue significantly different from EGPs but not from non-reacted control.

Table 1. Summary of human and lab animal microbiome studies on Maillard reaction products (AGE and EGP).